Ignite Creation Date:
2024-10-25 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06635213
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Effectiveness of Desensitisation and Pain Neuroscience Education in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Determination of the Effectiveness of Desensitisation and Pain Neuroscience Training in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain Phenotype
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of our study was to determine the effectiveness of desensitisation and pain neuroscience education in a group of patients with mixed phenotype pain neuropathic and nosiplastic
Detailed Description:
People between the ages of 18-65 diagnosed with Carpal Tunnel Sedrome who are suitable for the Nosiplastic pain phenotype and who volunteer to participate in the study will be included The 7 steps in the Clinical CriteriaRating System determined by the International Association for the Study of Pain IASP for Nosiplastic Pain will be applied to patients with CTS After determining the predominant pain phenotype in patients with CTS patients with mixed type neuropathic and nosiplastic pain phenotype will be randomly divided into two groups One group Group 1 will receive desensitisation and the other group Group 2 will receive desensitisation and pain neuroscience education Numerical rating scale NRS will be used for pain assessment Boston Carpal Tunnel Questionnaire - Symptom Severity Scale will be used for symptom severity assessment and Boston Carpal Tunnel Questionnaire - Functional Status Scale will be used for functional status assessment Pressure pain threshold will be measured with an algometer to evaluate hypersensitivity The Pain Catastrophising Scale and the Tampa Kinesiophobia Scale will be administered to the patients Normality of the data distribution will be assessed using the Shapiro-Wilk test Fischers exact test and chi-square test will be used to verify the relationship between categorical variables A mixed model ANOVA will be performed on 2 group 1 and group 2 x 3 time baseline post-intervention 3 months post-intervention different outcome measures pain intensity symptom severity functional status pain catastrophising and kinesiophobia to detect between-group differences
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None